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ILD.Abstract Aim of study: A retrospective study of diagnostic evaluation, safety and thoracoscopic
ﬁndings in 100 cases was done at thoracoscopy unit of Chest Department Mansoura University
Hospitals in the last two years.
Results: We studied 100 patients in two groups, ﬁrst group (G1) consisted of 85 male patients
(67.1%) with undiagnosed pleural effusion and the second group (G2) consisted of 15 undiagnosed
ILD female patients (60%).
Final histopathologic diagnosis in the ﬁrst group revealed metastatic adenocarcinoma in 35.3%,
para-pneumonic 44.7%, TB 10.6%, NHL7.1% and mesothelioma 2.4%, while in the second group
it was metastatic adenocarcinoma 6.7%, UIP 46.7%, NSIP 13.3%, TB 6.7%, BAC 13.3%, silicosis
6.7% and lastly LIP in 6.7%.
We found that time of ICT removal was signiﬁcantly lower in the ﬁrst group with p value 0.001
and complication incidences were variants; ﬁstula was signiﬁcantly lower in the ﬁrst group while
empyema and surgical emphysema were signiﬁcantly higher in the ﬁrst group with p value 0.001.
Conclusion: VAMT is a good tool for the diagnosis of undiagnosed pleural diseases and is
promising in ILDs, safe, and inexpensive with minimally tolerable complications.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Thoracoscopy is important in the diagnosis of pleural disease
and for pleurodesis in a recurrent pneumothorax or pleural
effusion. It has been safely and successfully performed by well
trained pulmonologists for several decades [1]. The introduc-
tion of modern video equipment and more reﬁned instrumen-
tation expanded the indications, both for interventional
pulmonary endoscopists performing video-assisted medicalrculosis.
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video-assisted thoracoscopic surgery (VATS) [2] .
Even after extensive diagnostic work-up of the pleural ﬂuid,
etiology of some pleural effusions remains undetermined [3].
Blind needle biopsies may establish the diagnosis in some addi-
tional cases, particularly in tuberculous pleurisy [4]. In a series
[5], of 1000 consecutive patients with pleural effusions, 215
cases remained undiagnosed after repeated pleural ﬂuid analy-
ses and performance of pleural biopsies. This is in agreement
with the results of several other authors who, without the
use of thoracoscopy, report that at least 20–25% of pleural
effusions remain undiagnosed [6].
Diffuse parenchymal lung disease (DPLD) encompasses a
heterogenous group of disorders, characterized by a spectrum
of inﬂammatory and ﬁbrotic changes affecting alveolar walls
and airspaces. Clinical manifestations are variable, but
progressive dyspnea, parenchymal inﬁltrates on chest
radiographs, and pulmonary dysfunction are characteristic.
DPLD may be caused by myriad etiologies, with differing
prognoses, natural history, and treatment approaches. Clinical
signs and symptoms overlap between differing diseases, but
salient differences in clinical, demographic, radiographic, and
histopathological patterns distinguish these diverse entities.
An initial approach to diagnosis requires incorporating these
various facets [10].
The aim of study: A retrospective study of diagnostic eval-
uation, safety and thoracoscopic ﬁndings of 100 cases was
done at the thoracoscopy unit of Chest Department Mansoura
University Hospitals in the last two years.
Patient and methods
This retrospective study includes 100 patients admitted to
Chest Medicine Department Mansoura University Hospital
Egypt from April 2012 to June 2014. Written consent was
obtained from all the patients before the procedure.
We included adult patients with undiagnosed exudative
pleural effusion or undiagnosed diffuse pulmonary inﬁltrate
and excluded patients with uncorrectable bleeding diathesis,
patients with uncontrolled cardiac co-morbidities like intract-
able arrhythmia and patients diagnosed by any other diagnos-
tic procedure.
Patients were divided into two groups, group one (G1)
included 85 patients with undiagnosed exudative effusionFigure 1 60 year old female presented with dyspnea for two months
VAMT and patient diagnosed as metastatic adenocarcinoma.and group two (G2) included 15 patients with diffuse
pulmonary inﬁltrates; all Patients were subjected to the follow-
ing: clinical evaluation; (Full history taking and clinical exam-
ination), routine laboratory investigation: (CBC-liver & kidney
function-bleeding proﬁle), chest X-ray and CT chest and bed-
side chest sonography if needed for localization of best site for
entry, pleural ﬂuid aspiration for biochemical examination,
AFB stain, total cell count, pleural ﬂuid culture and sensitivity
and cytological examination 3 samples, closed pleural biopsy
by Abrams needle, fibro-optic bronchoscopy and BAL for
cytology, AFB stain and culture.
Thoracoscopic examination was done using an 11 mm sin-
gle trocar thoracoscope that included the following: (i) Trocar
and Cannula with a valve. (ii) Telescope Bridge with the instru-
ment channel. (iii) 90 telescope rod lens with ﬁberoptic light
transmission and incorporation. (iv) Biopsy forceps and
injection needle and (v) Xenon light source. The procedure
was performed in a cleaned endoscopy room stocked with
the necessary medications and resuscitation equipment.
Patients must be in the Lateral decubitus position with the
affected side up. The patient should be given the standard
anesthetic premedication intramuscularly 30 min prior to the
procedure: Midazolam 5–10 mg IV was given. After localiza-
tion of the appropriate site of entry either in pleural effusion
or in interstitial lung disease. Induction of pneumothorax
was done in the interstitial lung disease and usually in the
mid axillary line in safety triangle. Local anesthesia was given
using xylocaine, a vertical incision was made through the skin
and subcutaneous tissue appropriate to the size of the trocar to
be used. Parietal pleural biopsies in case of pleural effusion
were taken from suspicious areas and visceral and lung biop-
sies in cases of parenchymal lung diseases using cupped lung
biopsy forceps with diathermy.
Follow up: At the end of procedure an appropriate inter-
costal tube was placed in the intercostal space and followed
up for any complication till diagnosis and tube removal.
IBM SPSS Statistics version 21 (IBM_ SPSS_ New York,
U.S.A) was used to analyze the data. Categorical variables
are expressed as numbers and percentages and continuous
variables as mean ± standard deviation. Fisher exact test
was used to detect a signiﬁcant difference between categorical
variables. Differences in means were compared using a t-test.
A p-value of <0.05 was considered statistically signiﬁcant
(see Figs. 1 and 2).showing bilateral diffuse nodular inﬁltrates four biopsies taken via
Figure 2 41 year old female diagnosed as metastatic adenocarcinoma by thoracoscopy appear as a nodular lesion in parietal pleura after
negative closed pleural biopsy and cytology from pleural ﬂuid three times.
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We studied 100 patients dividing into two groups: the ﬁrst
group consisted of 85 male patients (67.1%) with undiagnosed
pleural effusion and the second group consisted of 15 undiag-
nosed ILD female patients (60%). In the ﬁrst group, 34.1%
were smokers while only 13.3%, in the second group were
smokers. The thoracoscopic ﬁndings were as follows: we found
nodules in 37.6% in G1 and 13.3% in G2, adhesions were
37.6% and 6.7% in the two groups respectively. We found
thickening and mass in the pleural effusion group only by per-
cents 7.6 and 3.5, respectively, and lastly anthracosis was 4.7%
and 46.7%, in the two groups respectively. The final
histopathologic diagnosis in G1 was as follows: metastatic ade-
nocarcinoma in 35.3%, para-pneumonic 44.7%, TB 10.6%,
NHL 7.1% and mesothelioma 2.4%, while in G2 ﬁnal
histopathological results were as metastatic adenocarcinoma
6.7%, UIP 46.7%, NSIP 13.3%, TB 6.7%, BAC 13.3%, silico-
sis 6.7% and lastly LIP in 6.7%. We observed that time of ICT
removal was signiﬁcantly lower in G1 with p value 0.001, and
complication incidences were variants ﬁstula signiﬁcantly
lower while empyema and surgical emphysema were signiﬁ-
cantly higher in G1 with p value 0.001 (see Tables 1 and 2).
Discussion
We studied 100 patients divided into two groups, G1 com-
posed of 85 patients with undiagnosed pleural effusion (three
cytology and one closed pleural biopsy by Abrams needle)
and G2 of 15 patients with undiagnosed ILD (after HRCT,
BAL, and TBLB).
We found that the diagnostic yield of rigid thoracoscopy
was 100% in both groups, and the ﬁnal diagnosis was as fol-
lows: G1 44.8% was malignant (2.4% was mesothelioma,
7.1% was NHL, and 35.3% diagnosed as metastatic adenocar-
cinoma) and remaining 55.2% was inﬂammatory (44.6% para-
pneumonic and 10.6% TB) our results were better than those
of Agarwal et al. [12] who studied 128 patients with pleural
effusion 19 patients remained undiagnosed after 3 cytology
and closed pleural biopsy rigid thoracoscopy was done to 19
patients, the etiological diagnosis conﬁrmed in 13 of the 19patients (69%) (adenocarcinoma 10, poorly differentiated car-
cinoma 2 and mesothelioma), but our results were comparable
with those of Shaheen et al. [13] who studied 40 patients with
undiagnosed pleural effusion rigid and ﬂexible thoracoscopy
was carried out using a ﬁberoptic bronchoscope as a ﬂexible
thoracoscope and found that the diagnostic yield of ﬂexible
thoracoscope and that of rigid thoracoscope was 80%
(32/40) and 95% (38/40), respectively. And Prabhu and Nara-
simhan [7] performed pleuroscopy to 68 patients and found
that the overall diagnostic yield was 97%. Malignancy was
diagnosed in 24 patients, 22 patients had non-speciﬁc inﬂam-
mation, tuberculosis was found in 16 patients, empyema was
found in 2 patients, 1 patient had sarcoidosis, 1 patient had
normal pleura and it was non-diagnostic in 2 patients and bet-
ter than Mootha et al. [14] who studied 35 patients with undi-
agnosed pleural effusion and found that the overall diagnostic
yield of thoracoscopic pleural biopsy was 74.3% in patients
with undiagnosed pleural effusions. Pleural malignancy was
diagnosed in 48.6% of patients. There was only one case of
mesothelioma, and the rest were due to pleural metastasis.
Tuberculosis was diagnosed with pleural biopsy in 22.8% of
patients. Blanc et al. [15] concluded that medical thoracoscopy
appears to be efﬁcient and relatively safe in the management of
a pleural disease. Pleural adhesions can lower its diagnostic
value. Huang et al. [16] performed ﬂexi rigid thoracoscopy in
forty-seven patients with pleural effusion. The diagnostic accu-
racy rate of ﬂexi rigid thoracoscopy reached 93.6%. In con-
trast, Thangakunam et al. [17] performed thoracoscopy in 21
patients using a ﬂex-rigid thoracoscope. The indication was
pleural effusion with inconclusive or negative pleural ﬂuid
cytology and blind pleural biopsy in 18 of the 21 patients.
The thoracoscopic biopsy was positive in 12 of the18 patients
(66.7%). Also, Ng et al. [18] could achieve diagnosis with tho-
racoscopic pleural biopsy in only 45.5% (10/22) patients with
undiagnosed pleural effusions. This low diagnostic yield com-
pared with other studies may be due to insufﬁcient pleural
biopsy samples.
And in G2 the diagnostic yield was 100% and the ﬁnal
histopathologic diagnosis of thoracoscopic biopsies was as fol-
lows: 20% was malignant (13.3% BAC and 6.7% metastasis)
and 80% was benign lesion (46.7% UIP, 13.3 NSIP, 6.7% to
each of the following LIP, TB, and silicosis). Hatata et al.
Table 1 Age, sex, thoracoscopic ﬁnding and ﬁnal pathological
diagnosis in effusion group and ILD group.
Pleural eﬀusion group ILD group
Number 85 15
Age 11.15 + 52 5.1 + 47.53
Sex
Male 57 (67.1%) 6 (40%)
Female 28 (32.9%) 9 (60%)
Smoking habit 29 (34.1%) 2 (13.3%)
Thoracoscopic ﬁnding
Free 8 (9.4%) 5 (33.3%)
Nodules 32 (37.6%) 2 (13.3%)
Adhesion 32 (37.6%) 1 (6.7%)
Thickening 6 (7.1%) 0
Mass 3 (3.5%) 0
Anthracosis 4 (4.7%) 7 (46.7%)
Diagnosis
Metastatic 30 (35.3%) 1 (6.7%)
Para-pneumonic 38 (44.7%) 0
UIP 0 7 (46.7%)
NSIP 0 2 (13.3%)
TB 9 (10.6%) 1 (6.7%)
NHL 6 (7.1%) 0
BAC 0 2 (13.3%)
Mesothelioma 2 (2.4%) 0
Silicosis 0 1 (6.7%)
LIP 0 1 (6.7%)
Table 2 Time of ICT removal and complications in effusion
group and ILD group.
Pleural eﬀusion
group
ILD group p-value
Time of ICT removal 1.22 + 2.67 1.53 + 5.07 0.001
Complications
No 77 (90.6%) 9 (60%) 0.001
Fistula 0 4 (26.7%)
Empyema 3 (3.5%) 1 (6.7%)
S. Emphysema 5 (5.9%) 1 (6.7%)
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diagnosis was established in 12 patients: 4 patients had pri-
mary bronchogenic carcinoma while ﬁve patients had metas-
tases. Only three patients had a benign parenchymal disease.
Overall, thoracoscopy had a sensitivity of 80% for the diagno-
sis of peripheral parenchymal pulmonary lesions. Boutin et al.
[20] report a diagnostic yield of 100% of 20 cases with diffuse
parenchymal lung diseases. Lower diagnostic yields were
reported by Dijkman et al. [11], Vansteenkiste et al. [9] who
reported a diagnostic yield of 90% and 75%, respectively. This
difference may be due to the number and size of biopsies
taken.
Time of ICT removal of our study was signiﬁcantly better
in the G1 and this may be due to reasons such as for most
patients the G2 biopsies were taken from the lung itself and
so the incidence of ﬁstula formation was larger than that of
the second group (four patients in the second group and no
patients in the ﬁrst group) and incidences of empyema and sur-
gical emphysema were signiﬁcantly higher in the ﬁrst groupand this may be caused by the nature of diseases diagnosed
(44.7% para-pneumonic). Hatata et al. [19] found that pro-
longed air leak for more than ﬁve days was observed in only
one patient (6.7%). The air leaks were not related to the num-
ber or size of biopsies. Elnady et al. [8] in their study of lung
biopsy by medical thoracoscopy in patients with DPLDs
reported persistent air leak for 5 and 7 days, pneumothorax
after removal of the intercostal tube, and pain and minor
bleeding in 20%, 20%, 60%, and 10%, of patients respectively.
The reported incidence of empyema in the previous thoraco-
scopic studies varied from 0% in multiple studies [21,13]
0.5% (5 of 1145 cases) [22], 0.6% (1 of 147 cases) [23], 1%
(6 of 556 cases) [24], 2% (4 of 182 cases) [25], 2.5% (9 of
360 cases) [26], 4% (6 of 149 cases) [27], 4.8% (2 of 42 cases)
[28] to 10% (3 of 30 cases) [29].
Helal et al. (2014) report that post thoracoscopic complica-
tions in the studied group have occurred only in 4 patients
(10%). One patient (2.5%) developed surgical emphysema that
resolved spontaneously three days later and the other three
patients (7.5%) developed pain that was transient and con-
trolled by analgesics. In a study done by Vansteenkiste et al.
[9], no major complications such as important bleeding or per-
sistent ﬁstula occurred in this series. The procedure did not
cause temporary respiratory insufﬁciency.
We conclude that medical thoracoscopy has a high diagnos-
tic value in patients with pleural effusion and ILD, it is mini-
mally invasive, safe with minor tolerable complications.References
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